Dr. Rimawi on the Promise of the HER2CLIMB-02 Trial in HER2+ Breast Cancer

Mothaffar Fahed Rimawi, MD, discusses the promise of the phase 3 HER2CLIMB-02 trial in HER2-positive metastatic breast cancer.

Read the full article here

Related Articles